The biopharmaceutical company will research treatments for obesity and linked health conditions. The Department of Veterans Affairs (VA) recently finalized an agreement with biopharmaceutical company Hoth Therapeutics, which…
Read MoreObesity
FDA Approves Medication for Obstructive Sleep Apnea
First OSA drug treatment for obese adults offers new hope alongside diet and exercise. The FDA recently approved Zepbound (tirzepatide) as the first drug treatment for moderate to…
Read More
Medicare Proposal Expands Access to Care and Consumer Protections
CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…
Read More
FDA Approves Wegovy for Cardiovascular Risk Reduction
The injection becomes the first weight loss medication to address life-threatening cardiovascular events. The Food and Drug Administration has expanded the approved use of Wegovy (semaglutide) injection, making…
Read More
USDA Launches Nutrition Hub
Pilot program intended to counter diet-related diseases. The U.S. Department of Agriculture (USDA) has launched a pilot nutrition hub, in collaboration with Southern University, to provide science-based nutrition…
Read More